<DOC>
	<DOCNO>NCT02949362</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy teduglutide treatment child short bowel syndrome ( SBS ) complete TED-C13-003 study long-term period . It evaluate child fare TED-C13-003 study end . This study also offer teduglutide treatment eligible subject , regardless treatment receive TED-C13-003 .</brief_summary>
	<brief_title>Long-term Study Teduglutide Pediatric Subjects With Short Bowel Syndrome Who Completed TED-C13-003 Study</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<criteria>1 . Subject provide write informed consent ( subject , parent legal guardian , appropriate , subject inform assent ) participate study complete studyrelated procedure . 2 . Subject complete TEDC13003 study ( include subject standard care treatment arm ) . 3 . Subject understand willing able fully adhere study requirement define protocol . There exclusion criterion study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>